Tower Research Capital »

Unicycive Therapeutics shares owned by Tower Research Capital

Quarter-by-quarter ownership of Unicycive Therapeutics (UNCY) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Unicycive Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Unicycive Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Unicycive Therapeutics by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $11k 1.9k 5.77

More positions owned by Tower Research Capital

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Spdr Series Trust State Street Spd (SJNK)
Invesco Actively Managed Exc Ultra Shrt Dur (GSY)
Ishares Tr Russell 2000 Etf (IWM)
Advanced Micro Devices (AMD)
Wisdomtree Tr Floatng Rat Trea (USFR)
JPMorgan Chase & Co. (JPM)

View all positions for Tower Research Capital

Top funds holding Unicycive Therapeutics

Vivo Capital
Octagon Capital Advisors
Nantahala Capital Management
Dr. Jeffrey R. Jay, M.D.
Vanguard Group
Logos Global Management
Cantor Fitzgerald, L. P.
Geode Capital Management
Bnp Paribas Arbitrage, Snc
Dauntless Investment Group
OMERS Administration Corporation
State Street Corporation
Longwood Capital Partners
Squarepoint Ops
Susquehanna International

View all funds holding Unicycive Therapeutics